Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.62 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.62 |
| ▸ | CYP3A4 | P08684 | 4/20 | 0.59 |
| ▸ | TSHR | P16473 | 4/20 | 0.59 |
| ▸ | LMNA | P02545 | 1/20 | 0.55 |
| ▸ | CA2 | P00918 | 2/20 | 0.54 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.52 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.48 |
| ▸ | DNM1 | Q05193 | 2/20 | 0.48 |
| ▸ | ATM | Q13315 | 1/20 | 0.43 |
| ▸ | THRB | P10828 | 1/20 | 0.41 |
| ▸ | TP53 | P04637 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4354477 | 0.97 | ALDH1A1 (0.59) | ALDH1A1TDP1CYP3A4TSHRLMNA | |
| SCHEMBL3689153 | 0.97 | ALDH1A1 (0.59) | ALDH1A1TDP1CYP3A4TSHRLMNA | |
| SCHEMBL14125873 | 0.97 | ALDH1A1 (0.59) | ALDH1A1TDP1CYP3A4TSHRLMNA | |
| SCHEMBL6011884 | 0.97 | ALDH1A1 (0.59) | ALDH1A1TDP1CYP3A4TSHRLMNA | |
| SCHEMBL20746322 | 0.97 | ALDH1A1 (0.59) | ALDH1A1TDP1CYP3A4TSHRLMNA | |
| SCHEMBL1116216 | 0.97 | ALDH1A1 (0.59) | ALDH1A1TDP1CYP3A4TSHRLMNA | |
| SCHEMBL6011969 | 0.97 | ALDH1A1 (0.59) | ALDH1A1TDP1CYP3A4TSHRLMNA | |
| SCHEMBL9092266 | 0.97 | ALDH1A1 (0.59) | ALDH1A1TDP1CYP3A4TSHRLMNA | |
| SCHEMBL20746352 | 0.97 | ALDH1A1 (0.59) | ALDH1A1TDP1CYP3A4TSHRLMNA | |
| SCHEMBL28302263 | 0.97 | ALDH1A1 (0.59) | ALDH1A1TDP1CYP3A4TSHRLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 186 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2026043730-A1 | METHODS FOR PRODUCING AVIATION FUELS | CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) | 2026-02-26 | — | — | WO | claimed |
| US-12509607-B2 | Method for obtaining water-based paints using expanded polystyrene (EPS) waste and/or extruded polystyrene (XPS) waste as raw material | ACUNA ROUGIER CRISTINA LUCIA (CL) | 2025-12-30 | — | — | US | claimed |
| CN-120058495-A | Process for the preparation of mixed alkyl ketones and alkyl alcohols | 武汉希音新材料科技有限公司 | 2025-05-30 | — | — | CN | claimed |
| CN-118993844-A | Process for the preparation of mixed alkyl ketones and alkyl alcohols | 武汉希音新材料科技有限公司 | 2024-11-22 | — | — | CN | claimed |
| US-20230159784-A1 | METHOD FOR OBTAINING WATER-BASED PAINTS USING EXPANDED POLYSTYRENE (EPS) WASTE AND/OR EXTRUDED POLYSTYRENE (XPS) WASTE AS RAW MATERIAL | ACUNA ROUGIER CRISTINA LUCIA (CL) | 2023-05-25 | — | — | US | claimed |
| EP-4140678-A1 | METHOD FOR OBTAINING WATER-BASED PAINTS USING EXPANDED POLYSTYRENE (EPS) WASTE AND/OR EXTRUDED POLYSTYRENE (XPS) WASTE AS RAW MATERIAL | Acuña Rougier, Cristina Lucía (CL) | 2023-03-01 | — | — | EP | claimed |
| EP-3515971-B1 | PROCESS FOR FABRICATION OF PAINTS BASED ON EXPANDED POLYSTYRENE (EPS) WASTE | ACUNA ROUGIER CRISTINA LUCIA (CL) | 2022-04-13 | — | — | EP | claimed |
| WO-2021212247-A1 | METHOD FOR OBTAINING WATER-BASED PAINTS USING EXPANDED POLYSTYRENE (EPS) WASTE AND/OR EXTRUDED POLYSTYRENE (XPS) WASTE AS RAW MATERIAL | ACUNA ROUGIER CRISTINA LUCIA (CL) | 2021-10-28 | — | — | WO | claimed |
| US-20190338155-A1 | PROCESS FOR FABRICATION OF PAINTS BASED ON EXPANDED POLYSTYRENE (EPS) WASTE | ACUNA ROUGIER CRISTINA LUCIA (CL) | 2019-11-07 | — | — | US | claimed |
| EP-3515971-A1 | PROCESS FOR FABRICATION OF PAINTS BASED ON EXPANDED POLYSTYRENE (EPS) WASTE | Acuña Rougier, Cristina Lucía (CL) | 2019-07-31 | — | — | EP | claimed |
| WO-2018127755-A1 | PROCESS FOR FABRICATION OF PAINTS BASED ON EXPANDED POLYSTYRENE (EPS) WASTE | ACUNA ROUGIER CRISTINA LUCIA (CL) | 2018-07-12 | — | — | WO | claimed |
| CN-108034512-A | A kind of Multi-function dry washing material and preparation method thereof | 东莞智高化学科技有限公司 | 2018-05-15 | — | — | CN | claimed |
| CN-105518053-A | Aliphatic polycarbonate compositions and methods | NOVOMER INC | 2016-04-20 | — | — | CN | claimed |
| US-20160068638-A1 | ALIPHATIC POLYCARBONATE COMPOSITIONS AND METHODS | NOVOMER, INC. | 2016-03-10 | — | — | US | claimed |
| EP-2992031-A2 | ALIPHATIC POLYCARBONATE COMPOSITIONS AND METHODS | Novomer, Inc. (US) | 2016-03-09 | — | — | EP | claimed |
| WO-2014178972-A2 | ALIPHATIC POLYCARBONATE COMPOSITIONS AND METHODS | NOVOMER, INC. (US) | 2014-11-06 | — | — | WO | claimed |
| CN-122070352-A | Sustainable aviation fuel produced from normal alpha olefin byproducts and method thereof | 切弗朗菲利浦化学公司 | 2026-05-19 | — | — | CN | disclosed |
| EP-4399263-B1 | HEAVY OLIGOMER COMPOSITIONS OF A SELECTIVE 1-HEXENE AND 1-OCTENE CATALYST | CHEVRON PHILLIPS CHEMICAL CO LP (US) | 2026-05-06 | — | — | EP | disclosed |
| US-4136256-A | HYPOLIPIDEMIC, ANTIATHEROSCLEROTIC | AMERICAN CYANAMID COMPANY (US) | 1979-01-23 | — | — | US | disclosed |
| US-4117158-A | ANTILIPEMIC AGENTS | AMERICAN CYANAMID COMPANY (US) | 1978-09-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12509607-B2 | Method for obtaining water-based paints using expanded polystyrene (EPS) waste and/or extruded polystyrene (XPS) waste as raw material | RPS28, RPS27, RPS27L | ALDH1A1 2028/4885TDP1 1371/4885CYP3A4 2482/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.